- Report
- May 2023
- 1000 Pages
Global
From €3862EUR$3,995USD£3,318GBP
- Report
- July 2023
- 325 Pages
Global
From €5317EUR$5,500USD£4,567GBP
- Report
- March 2024
- 198 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- April 2024
- 89 Pages
Global
From €5414EUR$5,600USD£4,650GBP
- Report
- April 2024
- 504 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- January 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- August 2022
- 321 Pages
Global
From €4640EUR$4,799USD£3,985GBP
- Report
- September 2022
- 330 Pages
Global
From €4640EUR$4,799USD£3,985GBP
- Report
- January 2022
- 310 Pages
Global
From €4640EUR$4,799USD£3,985GBP
- Report
- March 2022
- 405 Pages
Global
From €4640EUR$4,799USD£3,985GBP
- Report
- April 2019
- 300 Pages
Global
From €4350EUR$4,499USD£3,736GBP
- Report
- October 2018
- 238 Pages
Global
From €3383EUR$3,499USD£2,906GBP
- Report
- March 2022
- 312 Pages
Global
From €6768EUR$7,000USD£5,813GBP
- Report
- July 2020
- 300 Pages
Global
From €5317EUR$5,500USD£4,567GBP
- Report
- September 2021
- 792 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- November 2020
- 524 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- March 2023
- 157 Pages
Global
From €5317EUR$5,500USD£4,567GBP
- Report
- March 2021
- 345 Pages
Global
From €1329EUR$1,375USD£1,142GBP
€2659EUR$2,750USD£2,284GBP
- Report
- May 2019
- 277 Pages
Global
From €1329EUR$1,375USD£1,142GBP
€2659EUR$2,750USD£2,284GBP
- Report
- December 2022
- 338 Pages
Global
From €4036EUR$4,175USD£3,467GBP
The Cellular Diagnostics market is a subset of the larger Genomics market, which focuses on the study of cells and their components. Cellular Diagnostics is the application of genomics to the diagnosis and treatment of diseases. It involves the use of genetic tests to identify and characterize genetic mutations, as well as to detect and monitor the progression of diseases. This type of testing is used to diagnose a wide range of conditions, including cancer, cardiovascular disease, and neurological disorders.
Cellular Diagnostics is a rapidly growing field, with new technologies and applications being developed to improve the accuracy and speed of diagnosis. This has enabled the development of personalized treatments, which are tailored to the individual patient's genetic makeup.
Companies in the Cellular Diagnostics market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Roche. Show Less Read more